Topline Capital Management LLC Buys 247,436 Shares of Nutex Health Inc. $NUTX

Topline Capital Management LLC grew its stake in Nutex Health Inc. (NASDAQ:NUTX) by 80.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 556,567 shares of the company’s stock after purchasing an additional 247,436 shares during the quarter. Nutex Health makes up approximately 9.9% of Topline Capital Management LLC’s investment portfolio, making the stock its 3rd largest holding. Topline Capital Management LLC owned approximately 10.02% of Nutex Health worth $57,505,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of NUTX. Pertento Partners LLP acquired a new position in Nutex Health in the 3rd quarter valued at about $27,940,000. Marshall Wace LLP boosted its holdings in shares of Nutex Health by 333.4% during the second quarter. Marshall Wace LLP now owns 94,548 shares of the company’s stock worth $11,770,000 after acquiring an additional 72,734 shares during the period. Divisadero Street Capital Management LP acquired a new position in shares of Nutex Health in the second quarter valued at approximately $7,481,000. Geode Capital Management LLC grew its position in shares of Nutex Health by 116.8% in the second quarter. Geode Capital Management LLC now owns 78,859 shares of the company’s stock valued at $9,819,000 after purchasing an additional 42,484 shares during the last quarter. Finally, Pacer Advisors Inc. bought a new position in shares of Nutex Health during the third quarter worth approximately $3,299,000. Institutional investors own 5.32% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Wall Street Zen cut Nutex Health from a “strong-buy” rating to a “hold” rating in a report on Saturday, March 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 29th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $252.50.

Nutex Health Stock Up 2.1%

NUTX stock opened at $88.80 on Friday. Nutex Health Inc. has a 52 week low of $45.88 and a 52 week high of $193.07. The business has a 50-day simple moving average of $129.03 and a 200 day simple moving average of $124.47. The company has a quick ratio of 3.39, a current ratio of 3.41 and a debt-to-equity ratio of 0.70. The company has a market cap of $618.94 million, a PE ratio of 9.89 and a beta of 0.03.

Nutex Health (NASDAQ:NUTX) last announced its quarterly earnings data on Thursday, March 5th. The company reported $1.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.56 by ($3.95). The firm had revenue of $151.68 million for the quarter, compared to analyst estimates of $258.82 million. Nutex Health had a return on equity of 17.67% and a net margin of 7.34%.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.